Daibao STC High-Speed Tubular Centrifuge: Advanced Separation for Biopharma

Daibao Machinery Equipment Co., Ltd., a leading Chinese high-tech enterprise, has revolutionized tubular centrifuge technology. By acquiring core technology from the Shanghai Centrifugal Machinery Research Institute in 2013, Daibao built on decades of expertise to develop the STC series—a fully automatic, high-speed tubular centrifuge that fills a critical industry gap and ends reliance on manual discharge processes.

The STC series is engineered for demanding biopharmaceutical applications, including cell harvest, fermentation broth clarification, and biotherapeutic purification. Its high-capacity rotor (φ140mm × 760mm) achieves speeds up to 14,000 rpm with a separation factor of 15,366 ×g, ensuring efficient and reliable separation even under stringent GMP standards.

Key innovation lies in full-process automation: a simple “one-button start/stop” enables unattended operation, reducing labor costs and human error. The intelligent control system monitors parameters in real time, ensuring consistent, sterile separation—critical for sensitive bioprocessing environments.

With over 600 global clients, including more than 200 biopharmaceutical companies such as Harbin Pharmaceutical Group, Tongrentang, Yunnan Baiyao, and Hengrui Medicine (over 20 publicly listed), Daibao’s tubular centrifuge has proven its value in high-stakes production. The STC series represents the next generation of separation technology, combining high speed, automation, and GMP compliance to meet the evolving needs of the biopharmaceutical industry.